Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0097 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |